Literature DB >> 8436458

Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children.

K Roos1, E Grahn, S E Holm, H Johansson, L Lind.   

Abstract

Recurrent streptococcal tonsillitis/pharyngitis is a great problem, especially in certain epidemiological situations. Patients treated with antibiotics often have a disturbed normal throat flora and may lack, e.g., alpha-streptococci known in vitro to have an interfering activity against group A streptococci. Thirty-one patients with recurrent streptococcal tonsillitis were given antibiotics for 10 days. At the end of this treatment they were sprayed in their mouths with four selected alpha-streptococcal strains known to have strong growth inhibiting activity in vitro against most beta-streptococci group A. The follow-up period after this colonization was 3 months. After alpha-streptococcal treatment, none of the patients attracted a new tonsillitis during the follow-up period while 8% of the controls had a second tonsillitis. Treatment of streptococcal tonsillitis/pharyngitis with antibiotics followed by recolonization with alpha-streptococci seems to hinder further recurrences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436458     DOI: 10.1016/0165-5876(93)90047-7

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  15 in total

Review 1.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora.

Authors:  Itzhak Brook; Perry A Foote
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  The Use of Probiotics in Head and Neck Infections.

Authors:  Kristian Roos; Stig Holm
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

4.  Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein.

Authors:  B A Degnan; M C Fontaine; A H Doebereiner; J J Lee; P Mastroeni; G Dougan; J A Goodacre; M A Kehoe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

6.  Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.

Authors:  S M Kuhn; J Preiksaitis; G J Tyrrel; T Jadavji; D Church; H D Davies
Journal:  Can J Infect Dis       Date:  2001-01

Review 7.  [Antibiotic therapy in otorhinolaryngology].

Authors:  P Federspil; P A Federspil
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

8.  Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.

Authors:  Jeremy P Burton; Philip A Wescombe; Jean M Macklaim; Melissa H C Chai; Kyle Macdonald; John D F Hale; John Tagg; Gregor Reid; Gregory B Gloor; Peter A Cadieux
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

9.  Draft Genome Sequence of the Oral Commensal Streptococcus oralis 89a with Interference Activity against Respiratory Pathogens.

Authors:  Hanna E Sidjabat; Eva Grahn Håkansson; Anders Cervin
Journal:  Genome Announc       Date:  2016-01-14

Review 10.  The Potential for Topical Probiotic Treatment of Chronic Rhinosinusitis, a Personal Perspective.

Authors:  Anders U Cervin
Journal:  Front Cell Infect Microbiol       Date:  2018-01-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.